Ten years after founding Ovid Therapeutics, CEO Jeremy Levin plans to step down and hand over the top spot to COO Meg Alexander.
Alexander will formally take the reins at the beginning of next year …
Welcome back to another edition of Endpoints Weekly. Two of the year’s major oncology conferences are coming up soon: AACR starting April 17, and ASCO
Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel
The price differential between the US and other countries “will be significantly narrower or smaller” going forward because of pressure from the Trump administration’s “most
The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma. The Massachusetts-based drugmaker had been pushing for a reconsideration by the
Five people with beta thalassemia who had their blood stem cells genetically altered no longer require regular blood transfusions to stay healthy. Their Chinese-made treatment
Ten years after founding Ovid Therapeutics, CEO Jeremy Levin plans to step down and hand over the top spot to COO Meg Alexander.
Alexander will formally take the reins at the beginning of next year …